Graphic of two hands shaking under a red and purple light
Manufacturing

Viridian, awaiting FDA decision, taps WuXi Bio in supply deal

Viridian aims to challenge Amgen in a blockbuster market, and it's now tapped Chinese CDMO giant WuXi Biologics in a manufacturing pact.
Eric Sagonowsky May 27, 2026 3:32pm
mountain climb steep cliff climber struggle

Previewing Akeso's high-stakes ASCO plenary for PD-1/VEGF

May 27, 2026 11:25am
Eliminating KRAS Why targeted protein degraders could redefinewhatspossible in cancer

Eliminating KRAS: How degraders could redefine cancer care

Brought to you by ASTELLAS
Large layoffs of employees Wooden figures of people going to the exit

J&J dismisses 56 from HQ as part of orthopedics separation

May 27, 2026 11:14am
Real-World Evidence in the AI Era What You Can Unlock Depends on What You Build On

RWE in the AI Era: What You Unlock Depends on What You Build On

Brought to you by Flatiron Health
acquisition merger MA chess game

CordenPharma to snap up peptide API maker with US, China sites

May 27, 2026 10:39am
More News

Outlook wins FDA appeal after formal dispute proceedings

May 27, 2026 8:26am

US healthcare, life sci could benefit from disruption: poll

May 27, 2026 8:00am
Fierce Biotech

FDA delays ruling on AstraZeneca drug after negative adcomm vote

May 27, 2026 4:43am

Eli Lilly wins argument over Noom’s GLP-1 dosing claims

May 27, 2026 2:09am